Dr. Lucas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
611 N 35th St
Morehead City, NC 28557Phone+1 252-222-5700Fax+1 252-222-5705
Education & Training
Duke University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1983 - 1985
Carolinas Medical CenterResidency, Internal Medicine, 1981 - 1983
ECU Health Medical Center/East Carolina UniversityInternship, Internal Medicine, 1980 - 1981
University of North Carolina at Chapel Hill School of MedicineClass of 1980
Certifications & Licensure
NC State Medical License 1981 - 2025
GA State Medical License 1988 - 2001
AR State Medical License 1986 - 1989- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2011-2013
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
- Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting Start of enrollment: 2012 Jan 01
- A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) Start of enrollment: 2012 Jul 01
Publications & Presentations
PubMed
- 199 citationsEffect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.Thomas W. Martens, Roy W. Beck, Ryan Bailey, Katrina J. Ruedy, Peter Calhoun
JAMA. 2021-06-08 - 19 citationsGlucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial.Carel W le Roux, Oren Steen, Kathryn J Lucas, Elena Startseva, Anna Unseld
The Lancet. Diabetes & Endocrinology. 2024-03-01 - 54 citationsTropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial.Arun J Sanyal, Patricia Lopez, Eric J Lawitz, Kathryn J Lucas, Juergen Loeffler
Nature Medicine. 2023-02-01
Press Mentions
Investigational Liver Drug Also Effective in Patients with HypothyroidismMay 15th, 2022
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
